Press Releases

Press Releases

Octagos Health announces strategic investments in product, AI and talent

Following its recent $43 million Series B funding, the company is expanding its data integration capabilities to include a broader range of devices, including wearables, heart failure monitoring, and remote patient monitoring.

Elutia announces first patient implant of EluPro, the world’s first drug-eluting bioenvelope for cardiac pacemakers and neurostimulators

The procedure was performed in Greenville, North Carolina.

2023 Hearst Health Prize - AI for Incidental CAC

Congratulations to Stanford Medicine on winning the 2023 Hearst Health Prize for its artificial intelligence solution that helps identify patients at risk for heart attack by scoring incidental coronary artery calcium (CAC) on non-gated chest CTs.

DASI Simulations' PrecisionTAVI gets CMS Hospital Outpatient Billing Code

Predictive model generation for pre-planning a cardiac procedure now reimbursable by Medicare at approximately $1,000 per model

 

Echo IQ's breakthrough research on cardiovascular health continues with unveiling of AI-driven aortic stenosis and mitral regurgitation detection results at ESC 2023 Congress

Late-Breaking Science sessions reveal revolutionary findings on severe aortic stenosis and mild-to-severe mitral regurgitation identification through innovative AI technology.

 

Keystone Perfusion Services, PC recognized for life-saving contribution during COVID-19 pandemic, secures fifth consecutive year on Inc. 5000 list
| Submitted by: Keystone Perfusion Services, PC

The company's multifaceted healthcare staffing solutions play a pivotal role in transforming patient care and elevating industry standards.

 

Corazon and the Society for Cardiovascular Angiography and Interventions announce partnership

The agreement formally endorses Corazon’s cardiovascular accreditation.

Arineta announces SpotLight Duo, the world’s first dedicated cardiovascular and thoracic CT system

Arineta Cardio Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and SpotLight Duo family of cardiovascular CT scanners.

Study Confirms Ultromics’ AI Can Improve HFpEF Detection Using a Single Echocardiogram View

 

Researchers and engineers at Mayo Clinic and Ultromics developed technology that can detect HFpEF using a single A4C echocardiogram clip, to help clinicians detect a complex form of heart failure easily and accurately. 

 

Cassling connects cardiologists with revolutionary AI software

The Midwest company will begin offering EchoSolv, an artificial intelligence clinical decision support platform designed to help detect severe aortic stenosis, to providers throughout the country.

 

DASI Simulation’s Precision TAVI earns FDA clearance
| Submitted by: DASI Simulations

Precision TAVI is the first FDA-approved predictive modeling tool for medical teams planning TAVR procedures.

 

 

RecoverRite®, American College of Cardiology Collaborate to Change the Face of Cardiovascular Patient Education

RecoverRite’s Online Heart Learning Center to feature ACC’s CardioSmart patient tools and resources.

Study shows PulseAI’s deep learning algorithm outperforms the Apple Watch ECG algorithm in detecting atrial fibrillation

PulseAI, a leader in the development of cutting-edge AI-powered ECG software, has released the results of a clinical study that has shown the superiority of its deep learning AI over the Apple Watch ECG algorithm in the detection of atrial fibrillation.

 

$20M gift announced by the Rooney Foundation in support of enhanced cardiac care at NCH

NAPLES, Fla. – February 20, 2023   The NCH Healthcare System is proud to announce a $20 million naming gift from the Rooney Foundation, which is the philanthropic arm of the former U.S. Representative for Florida's 19th congressional district and his wife, Francis and Kathleen Rooney.  In recognition of increasing their $8 million pledge announced last July, the entire cardiac program across NCH Healthcare System will be renamed “The Rooney Heart Institute.”

NCH announces second historic gift in as many weeks totaling a record $40M in support of enhanced care

NAPLES, Fla. – February 21, 2023   On the heels of our historic $20 Million gift announcement made last week, NCH is proud to announce yet a second $20 million naming gift in as many weeks from Diana and Don Wingard.  This generous gift will provide the necessary funds to ensure that the NCH Stroke program continues to provide the highest level of care and treatment to patients in Southwest Florida.  Additionally, in recognition of the extraordinary pledge, the entire stroke program across NCH will be renamed the “Wingard Stroke Institute.”

Patient Image Exchange puts patients 'in the driver’s seat'

When using this service, patients have the ability to upload and share data without limitations. From radiology CDs to PDFs or JPG files, patients can use their smartphone connected to the Patient Image Exchange app and upload images, share lab results, immunizations records, nurses’ notes, dental images and much more.

 

Ancora Heart appoints David J. Tucker as chief financial officer

Ancora Heart has hired senior financial leader David J. Tucker as its chief financial officer. This is the company's second C-suite hire in 2022, following the addition of Mark Miles as chief commercial officer in June.

Geneticure presents data successfully identifying responders and non-responders to renal denervation using genetic screening

Geneticure, a global leader in the genetic variability of response to hypertension treatments, presented data at the 2022 American Heart Association Scientific Sessions meeting from a recent clinical study in which they were able to successfully predict patients who will respond to renal denervation (RDN). In addition, the Geneticure test for renal denervation also identified patients with an increase in blood pressure, following the procedure.

Cardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023

Long-awaited milestone gives physicians and their patients greater access to prescription cardiac arrhythmia detection solutions, including the company’s Cardea SOLO™ ECG System

NextGen Healthcare tapped by Advanced Heart Group to enhance patient experience, boost operational efficiency

This partnership reflects NextGen Healthcare’s deepening commitment to supporting cardiology practices nationwide. Research shows that nearly 50 percent of adults in the United States have some form of cardiovascular disease today—a rate expected to grow to 61 percent by 2050.

Philips presents study results at Heart Rhythm annual meeting demonstrating benefits of its AI-powered cardiac monitoring solutions

With cardiovascular disease on the rise, clinicians and health systems continue to look for ways to deliver high-quality care that is both timely and cost-effective.

First look at data on Biosense Webster Dual Energy THERMOCOOL SMARTTOUCH SF platform for atrial fibrillation presented at EHRA Congress

The Dual Energy THERMOCOOL SMARTTOUCH SF Catheter is the first dual energy pulsed field (PF) ablation / radiofrequency (RF) ablation catheter integrated with a PF and RF ablation index.

PaceMate hits 100,000th patient transmission milestone with cutting-edge ambulatory remote monitoring platform

PaceMate, a market-leading cardiac remote monitoring and cardiac data management platform, announced today the completion of its 100,000th ambulatory patient transmission managed through PaceMateLIVE.

Biotronik announces collaboration with AliveCor as first in a series of strategic partnerships to disrupt cardiac digital health with AI-enabled solutions

BIOTRONIK has announced a new partnership with AliveCor.

AirECMO and REVA Launch Cooperation
| Submitted by: Keystone Perfusion Services, PC

AirECMO, Inc., a division of Keystone Perfusion Services, P.C. announces a strategic partnership with industry leading air ambulance provider, REVA, to provide ECMO transportation capabilities globally. ECMO is an extracorporeal technique of providing prolonged cardiac and respiratory support to persons whose heart and lungs are unable to maintain hemodynamic stability.

Ultromics receives FDA Clearance for a first-of-kind solution in Echocardiography to help clinicians diagnose disease

EchoGo Pro was trialed and validated in the UK and US, improving the diagnostic accuracy of clinicians for coronary artery disease.

Medtronic VenaSeal(TM) Closure System Demonstrates Durable and Consistent Outcomes at Five Years in Patients with Chronic Venous Disease

DUBLIN and LONDON — April 17, 2019 — Medtronic plc (NYSE:MDT) today announced five-year outcomes from the VeClose Extension Study. Nick Morrison, M.D., Center for Vein Restoration, Mesa, Ariz., presented at the 2019 Charing Cross Symposium in London.

BIOTRONIK Launches PK Papyrus Covered Coronary Stent in the US

LAKE OSWEGO, Ore., April 10, 2019 — BIOTRONIK today announced the United States (US) commercial launch of the PK Papyrus® covered coronary stent system for use in the emergency treatment of acute coronary perforations.

Cardiovascular research scientists in Cincinnati and Houston awarded $1 million for revolutionary studies of heart disease and stroke

DALLAS, April 9, 2019 — A research scientist from Cincinnati studying how the heart can repair itself and a research scientist from Houston looking into specific genetic causes of stroke each received $1 million awards from the American Heart Association, the world’s leading voluntary organization focused on heart and brain health and research.

New Data Show Encouraging Economic Outcomes for Medtronic HeartWare(TM) HVAD(TM) System

DUBLIN and ORLANDO, Fla. — April 8, 2019 — Medtronic plc (NYSE:MDT) today announced data showing promising economic outcomes for the Medtronic HeartWare(TM) HVAD(TM) System after analyzing multiple clinical studies.

Medtronic HeartWare(TM) HVAD(TM) System Demonstrates Reduction in Total Strokes, Disabling Strokes and Stroke-Related Mortality with Blood Pressure Management
| Submitted by: Medtronic

DUBLIN and ORLANDO, Fla. — April 5, 2019 — Medtronic plc (NYSE:MDT) today announced the results of an analysis on the impact of stroke severity in patients receiving its HeartWare(TM) HVAD(TM) System as destination therapy, showing that targeted blood pressure management helped reduce serious strokes.

swyMed Partners with Life Image to Expand Access to Integrated Telestroke Solution to Help Patients at Rural and Community Hospitals Gain Access to Stroke Specialists

Newton, Mass. – March 28, 2018 – Life Image, the world's largest global network for sharing clinical and imaging data that is powered by industry leading interoperability standards, and swyMed, a leading provider of mobile telemedicine solutions, today announced a new strategic partnership to enhance telestroke capabilities.

BD Announces Launch of UltraScore™ 014 Focused Force PTA Balloon

FRANKLIN LAKES, N.J., April 1, 2019 – BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of the UltraScore™ 014 Focused Force PTA Balloon.

Ebit (Esaote Group) and DiA Imaging Analysis have partnered offering Advanced AI-based Cardiac Ultrasound Analysis

BE'ER SHEVA, Israel — Genoa, Italy — DiA Imaging Analysis, a leading provider of artificial intelligence (AI)-powered ultrasound analysis tools, announced today that it has partnered with the Italian healthcare IT company Ebit (Esaote Group), to offer DiA’s LVivo Cardiac Toolbox as an integrated part of Ebit's SUITESTENSA CVIS (Cardiovascular Information System) PACS.

Impella RP Post-Approval Study Data Presented at ACC 2019

NEW ORLEANS — Abiomed (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies and the maker of the Impella RP heart pump, announces that survival data from the 18 month post-approval study of 42 Impella RP patients was presented at the American College of Cardiology’s (ACC) 68th Annual Scientific Session in New Orleans.

FDA Approves Industry's Smallest, Slimmest 3T Tachycardia Devices from BIOTRONIK

LAKE OSWEGO, Ore., March 14, 2019 — BIOTRONIK today announced FDA approval of the Acticor and Rivacor high-voltage cardiac rhythm management (CRM) device families for treatment of patients with cardiac arrhythmias. The six new tachycardia solutions include Rivacor VR-T, Rivacor DR-T, Rivacor HF-T QP, Acticor DX, Acticor CRT-DX Bipolar and Acticor CRT-DX.

Northwestern Medicine and Eko Partner to Improve Valvular Heart Disease Screening Using Machine Learning Algorithms

CHICAGO, March 7, 2019  — Northwestern Medicine Bluhm Cardiovascular Institute is pioneering the use of artificial intelligence (AI) for cardiac screening in a new study of Eko’s cardiac monitoring platform. The study aims to demonstrate that Eko’s digital stethoscopes and AI algorithms can interpret heart sounds accurately to help screen for pathologic heart murmurs and valvular heart disease.

Aidoc announces CE mark for the first AI-based workflow tool for Pulmonary Embolism

Aidoc’s solution for flagging and prioritizing pulmonary embolisms is now commercially available in Europe

iSchemaView Launches RAPID™ ANGIO

Menlo Park, Calif. — February 28, 2019 — iSchemaView, the worldwide leader in advanced imaging for stroke care and research, today announced RAPID ANGIO, a complete neuroimaging solution for the angiography suite that integrates iSchemaView’s RAPID software with syngo DynaCT Multiphase from Siemens Healthineers.

$100 Million Invested in Clinical Research for Impella

DANVERS, Mass., February 20, 2019 – In a milestone for scientific research, Abiomed (NASDAQ: ABMD) has now invested more than $100 million over the past five years in clinical research on the Impella heart pump platform. Abiomed’s commitment to clinical research is detailed on a new webpage that launched today.